Immune-Onc Therapeutics

About:

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

Website: http://www.immune-onc.com/

Twitter/X: ImmuneOnc

Top Investors: National Cancer Institute, Vivo Capital, Northern Light Venture Capital, Octagon Capital Advisors, BOCOM International

Description:

Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.

Total Funding Amount:

$140M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)immuneonc.com

Founders:

Charlene Liao, Guo Liang Yu

Number of Employees:

11-50

Last Funding Date:

2023-01-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai